Literature DB >> 2788877

Frequency of and risk factors for allergy in primary school children: results of a population survey.

A M Angioni1, G Fanciulli, C Corchia.   

Abstract

During May 1986, a survey to assess the frequency of allergic disorders was conducted among primary school children of Alghero, Sardinia, using a structured self-administered questionnaire. The following problems were investigated: allergic conjunctivitis, asthma, wheezing, allergic rhinitis, urticaria and eczema. Of the original 1823 questionnaires distributed, 1961 (92.8%) were completed by parents and returned. Overall, 238 children (14.1%) were reported to have shown at least one episode of one or more of the above and were regarded as 'allergic'. Among the potential risk factors investigated, statistically significant differences (P less than 0.05) between allergic and non-allergic children were only found for history of allergy in at least one parent (odds ratio, OR = 2.2) and exposure to passive smoking (OR = 1.4).

Entities:  

Mesh:

Year:  1989        PMID: 2788877     DOI: 10.1111/j.1365-3016.1989.tb00376.x

Source DB:  PubMed          Journal:  Paediatr Perinat Epidemiol        ISSN: 0269-5022            Impact factor:   3.980


  3 in total

1.  Demographic study of paediatric allergic conjunctivitis within a multiethnic patient population.

Authors:  A J Singh; R S K Loh; J A Bradbury
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

2.  Association of parental eczema, hayfever, and asthma with atopic dermatitis in infancy: birth cohort study.

Authors:  N Wadonda-Kabondo; J A C Sterne; J Golding; C T C Kennedy; C B Archer; M G S Dunnill
Journal:  Arch Dis Child       Date:  2004-10       Impact factor: 3.791

Review 3.  Active or passive exposure to tobacco smoking and allergic rhinitis, allergic dermatitis, and food allergy in adults and children: a systematic review and meta-analysis.

Authors:  Jurgita Saulyte; Carlos Regueira; Agustín Montes-Martínez; Polyna Khudyakov; Bahi Takkouche
Journal:  PLoS Med       Date:  2014-03-11       Impact factor: 11.069

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.